Frier Levitt Assisted Procurement of Much Needed COVID-19 Testing Kit into U.S.
Frier Levitt is pleased to announce that its COVID-19 Task Force assisted a national distributor to obtain an authorized distributorship of COVID-19 testing kits from a renowned South Korean manufacturer. This is a crucial development amid the shortage of novel coronavirus testing kits and the increasing demand in the U.S.
Frier Levitt’s COVID-19 Task Force is headed by Co-Founding Partner, Jonathan E. Levitt, Esq., New York Office Managing Partner, John E. Morrone, Esq. and supported by clinician attorneys and seasoned litigators including pharmacist-attorney Dae Y. Lee, Pharm.D., Esq., CPBS™. Mr. Lee, a Korean native, envisions that more molecular diagnostic analyzer and reagent manufacturers based in Asia will be looking for opportunities in the U.S. market.
Frier Levitt has been assisting clients with compliance throughout the drug and healthcare supply chain by navigating through a complex web of regulations set forth by various federal agencies including, but not limited to, Environmental Protection Agency, Food and Drug Administration, and Federal Trade Commission. If you are a manufacturer seeking advice on pharmaceutical/medical device regulations in the U.S., contact Frier Levitt today to speak with an attorney.